All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Other | 2020-005051-20 | Determination Of Molecular Status And Benefit Of Use Fludeoxyglucose (18F-FDG) In PET/CT imagining In Juvenile Patients With Histiocytosis Oszacowanie profilu molekularnego oraz przydatności i bezp... | not-yet-due | |
| Other | 2020-005052-37 | Optymalizacja czasu leczenia i dawkowania wemurafenibu u małoletnich pacjentów z opornymi na konwencjonalną terapię rozrostami z komórek histiocytarnych z obecnością mutacji w genie BRAF. Optimaliz... | not-yet-due | |
| Other | 2020-005053-25 | Optimalization Of The Time And Dosage Of Trametinib In BRAF Negative Juvenile Patients With Refractory Histiocytosis Or After Failure Of Vemurafenib Treatment. Optymalizacja czasu leczenia i dawkow... | not-yet-due | |
| Other | 2021-005339-22 | To evaluate the efficacy and safety of regorafenib in patients with refractory primary bone tumors. Ocena skuteczności i bezpieczeństwa zastosowania regorafenibu u pacjentów z opornymi na leczenie ... | not-yet-due | |
| Other | 2022-003812-98 | To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma. Ocena skuteczności i bezpieczeństwa zastosowania naksytamabu u pacjentów z opornym na leczenie mięsaki... | not-yet-due |